ReviewMolecular therapy. Oncology2026
Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers.
Kazem Mashayekhi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it